omega-n-methylarginine has been researched along with bosentan anhydrous in 5 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (bosentan anhydrous) | Trials (bosentan anhydrous) | Recent Studies (post-2010) (bosentan anhydrous) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 1,836 | 215 | 630 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | bosentan anhydrous (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | 0.095 | |
| Endothelin receptor type B | Homo sapiens (human) | 0.3044 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.2317 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 0.0047 | |
| Endothelin-1 receptor | Sus scrofa (pig) | 0.0075 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
| Baylis, C; Zhang, XZ | 1 |
| Baylis, C; Qiu, C | 1 |
| Bröijersén, A; Erbas, D; Gonon, AT; Pernow, J; Valen, G | 1 |
| Adams, MR; Celermajer, DS; Ilsar, R; Kritharides, L; Levitt, J; Ng, MK | 1 |
5 other study(ies) available for omega-n-methylarginine and bosentan anhydrous
| Article | Year |
|---|---|
Effects of the non-peptide, non-selective endothelin antagonist, bosentan, on regional haemodynamic responses to NG-monomethyl-L-arginine in conscious rats.
Topics: Animals; Arginine; Bosentan; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hemodynamics; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Sulfonamides | 1996 |
Endothelin mediates renal vascular memory of a transient rise in perfusion pressure due to NOS inhibition.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Diuresis; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Kidney; Male; Natriuresis; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Perfusion; Pressure; Rats; Rats, Sprague-Dawley; Renal Circulation; Sulfonamides; Vascular Resistance | 1999 |
Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Kidney Glomerulus; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Renal Circulation; Sulfonamides | 1999 |
Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
Topics: Adenosine Diphosphate; Animals; Bosentan; Cardiotonic Agents; Coronary Circulation; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hemodynamics; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasodilator Agents | 2004 |
Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension.
Topics: Acetylcholine; Aged; Antihypertensive Agents; Arginine; Bosentan; Endothelium, Vascular; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Pulmonary Artery; Sulfonamides; Ultrasonography | 2010 |